Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Assets: 2021-2025

Historic Return on Assets for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Sep 2025 value amounting to 0.05%.

  • Kiniksa Pharmaceuticals International's Return on Assets rose 20.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 20.00%. This contributed to the annual value of -0.08% for FY2024, which is 4.00% up from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Return on Assets stood at 0.05%, which was up 588.16% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Return on Assets ranged from a high of 0.68% in Q2 2023 and a low of -0.68% during Q4 2021.
  • Moreover, its 3-year median value for Return on Assets was -0.03% (2025), whereas its average is 0.08%.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Return on Assets soared by 126bps in 2022, and later tumbled by 84bps in 2024.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Return on Assets (Quarterly) stood at -0.68% in 2021, then soared by 126bps to 0.58% in 2022, then plummeted by 70bps to -0.12% in 2023, then rose by 4bps to -0.08% in 2024, then rose by 20bps to 0.05% in 2025.
  • Its Return on Assets stands at 0.05% for Q3 2025, versus 0.01% for Q2 2025 and -0.03% for Q1 2025.